Riesgo de fracturas no vertebrales en mujeres posmenopáusicas en tratamiento antirresortivo

Andersen, 2007, Osteoporosis in the older woman, Clin Obstet Gynecol, 50, 752, 10.1097/GRF.0b013e3180dba614 Chrischilles, 1991, A model of lifetime osteoporosis impact, Arch Intern Med, 151, 2026, 10.1001/archinte.1991.00400100100017 Black, 2001, An assessment tool for predicting fracture risk in postmenopausal women, Osteoporos Int, 12, 519, 10.1007/s001980170072 Grupo de trabajo de menopausia y postmenopausia. Guía de práctica clínica sobre menopausia y postmenopausia. Barcelona: Sociedad Española de Ginecología y Obstetricia. Asociación Española para el estudio de la Menopausia. Sociedad Española de Medicina de Familia y Comunitaria y Centro Cochrane Iberoamericano, 2004. Díaz Curiel, 2001, Prevalencia de osteoporosis determinada por densitometría en la población femenina española, Med Clin (Barc), 116, 86, 10.1016/S0025-7753(01)71732-0 Hermoso de Mendoza, 2003, Clasificación de la osteoporosis. Factores de riesgo. Clínica y diagnóstico diferencial, An Sist Sanit Navar, 26, 29, 10.4321/S1137-66272003000600004 Siris, 2001, Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment, JAMA, 286, 2815, 10.1001/jama.286.22.2815 The European Agency for the Evaluation of Medicinal Products. Committee for proprietary Medicinal Products (EMEA.CPMP). Note for guidance on postmenopausal osteoporosis in women. January, 2001. National Institute of Clinical Excellence (NICE). Bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. Technology Appraisal Guidance 87. January, 2005. O’Neill, 1996, The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study, J Bone Miner Res, 11, 1010, 10.1002/jbmr.5650110719 Sosa, 1998, Datos actualizados sobre epidemiología de la fractura osteoporótica en España, Rev Esp Enf Metab Óseas, 7, 174 Serra, 2002, Epidemiología de la fractura de cadera en la ancianidad España, An Med Interna, 19, 389 Naves, 2005, Determinants of incidente of osteoporotic fractures in the females Spanish population older than 50, Osteoporos Int, 16, 2013, 10.1007/s00198-005-1983-4 Kanis, 2002, Diagnosis of osteoporosis and assessment of fracture risk, Lancet, 359, 1929, 10.1016/S0140-6736(02)08761-5 Delmas, 2002, Treatment of postmenopausal osteoporosis, Lancet, 359, 2018, 10.1016/S0140-6736(02)08827-X Boonen, 2005, Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies, Osteoporos Int, 16, 1291, 10.1007/s00198-005-1945-x